Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Keros Therapeutics will use the proceeds from the Partners Healthcare and Medison Pharma-backed round to push its rare muscle disease drugs into clinical trials.

Vorwerk Ventures returned to reinvest in the smart luggage developer as part of an $11.4m round that also featured Project A and Milano Investment Partners.

Proceeds from the Alexandria Real Estate Equities-backed series B round will advance the company's development of progenitor cell-related medicines for hearing loss.

Celgene and Evotec both invested in Exscientia, as the automated drug discovery services provider added Roche to its roster of development partners.

Celgene and Evotec have put capital into Exscientia as the Dundee-founded automated drug discovery services provider added Roche to its roster of development partners.

The Century Internet-backed broadband network technology provider has raised $14.6m in a round led by Qualcomm Ventures.

Autoimmune disease therapy spinout Cabaletta Bio's series B round brought its total to at least $88m allowed the university to pare back its shareholding.

Ctrip and Japan Airlines-backed supersonic aircraft developer Boom has completed a $100m series B round that brought its total funding to more than $140m.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.